Failed efficacy of soluble human CD83-Ig in allogeneic mixed lymphocyte reactions and experimental autoimmune encephalomyelitis: Implications for a lack of therapeutic potential

Immunology Letters

Volumn 115, Issue 1, 2008, Pages 9-15

  Pashine, Achal ^a   Göpfert, Ulrich ^b   Chen, Jinzhi ^a   Hoffmann, Eike ^b   Dietrich, Paul S ^a   Peng, Stanford L ^a  

^a ROCHE BIOSCIENCE   (United States)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

CD83; Dendritic cells; Experimental autoimmune encephalomyelitis; Mixed lymphocyte reaction; Multiple sclerosis

Indexed keywords

ALLOANTIGEN; CD83 ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; DENDRITIC CELL; EUKARYOTIC CELL; LYMPHOCYTE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT FAILURE;

ANIMALS; ANTIGENS, CD; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOGLOBULINS; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS;

EID: 37549070679     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.10.015     Document Type: Article

References (26)

1. Fujimoto Y., and Tedder T.F. CD83: a regulatory molecule of the immune system with great potential for therapeutic application. J Med Dental Sci 53 (2006) 85-91
2. Zinser E., Lechmann M., Golka A., Lutz M.B., and Steinkasserer A. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J Exp Med 200 (2004) 345-351
3. Lechmann M., Krooshoop D.J., Dudziak D., Kremmer E., Kuhnt C., Figdor C.G., et al. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 194 (2001) 1813-1821
4. Senechal B., Boruchov A.M., Reagan J.L., Hart D.N., and Young J.W. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103 (2004) 4207-4215
5. Dudziak D., Nimmerjahn F., Bornkamm G.W., and Laux G. Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation. J Immunol 174 (2005) 6672-6676
6. Xu J.F., Huang B.J., Yin H., Xiong P., Feng W., Xu Y., et al. A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts. Transpl Int 20 (2007) 266-276
7. Munoz A. Press Release, Durham, NC, April 26, 2006, Argos Therapeutics, Beckman Coulter sign license agreement. CD83 licensure to advance work on autoimmune disorders, transplant rejection therapy; 2006. http://www.argostherapeutics.com/pdfs/CD83argos_beckman_press_release.pdf. Last accessed 27 November 2007.
8. Zhou L.J., Schwarting R., Smith H.M., and Tedder T.F. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149 (1992) 735-742
9. Edelman G.M., Cunningham B.A., Gall W.E., Gottlieb P.D., Rutishauser U., and Waxdal M.J. The covalent structure of an entire γG immunoglobulin molecule. Proc Natl Acad Sci USA 63 (1969) 78-85
10. Chapman B.S., Thayer R.M., Vincent K.A., and Haigwood N.L. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res 19 (1991) 3979-3986
11. Shen E.S., Cooke G.M., and Horlick R.A. Improved expression cloning using reporter genes and Epstein-Barr virus ori-containing vectors. Gene 156 (1995) 235-239
12. Langle-Rouault F., Patzel V., Benavente A., Taillez M., Silvestre N., Bompard A., et al. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J Virol 72 (1998) 6181-6185
13. Schlaeger E.-J., and Christensen K. Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology 30 (1999) 71-83
14. Meissner P., Pick H., Kulangara A., Chatellard P., Friedrich K., and Wurm F.M. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 75 (2001) 197-203
15. Durocher Y., Perret S., and Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30 (2002) E9
16. Girard P., Derouazi M., Baumgartner G., Bourgeois M., Jordan M., Jacko B., et al. 100-liter transient transfection. Cytotechnology 38 (2002) 15-21
17. Pham P.L., Perret S., Doan H.C., Cass B., St-Laurent G., Kamen A., et al. Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Biotechnol Bioeng 84 (2003) 332-342
18. Link A.J., Eng J., Schieltz D.M., Carmack E., Mize G.J., Morris D.R., et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17 (1999) 676-682
19. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179 (1994) 1109-1118
20. Hron J.D., Caplan L., Gerth A.J., Schwartzberg P.L., and Peng S.L. SH2D1A regulates T-dependent humoral autoimmunity. J Exp Med 200 (2004) 261-266
21. Scholler N., Hayden-Ledbetter M., Dahlin A., Hellstrom I., Hellstrom K.E., and Ledbetter J.A. Cutting edge: CD83 regulates the development of cellular immunity. J Immunol 168 (2002) 2599-2602
22. Lechmann M., Kotzor N., Zinser E., Prechtel A.T., Sticht H., and Steinkasserer A. CD83 is a dimer: comparative analysis of monomeric and dimeric isoforms. Biochem Biophys Res Commun 329 (2005) 132-139
23. + T cell development in the thymus. Cell 108 (2002) 755-767
24. Luthje K., Cramer S.O., Ehrlich S., Veit A., Steeg C., Fleischer B., et al. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells. Eur J Immunol 36 (2006) 2035-2045
25. Ma-Krupa W., Jeon M.S., Spoerl S., Tedder T.F., Goronzy J.J., and Weyand C.M. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 199 (2004) 173-183
26. + T cells and preferential enrichment for antigen specificity. Blood 107 (2006) 1528-1536